Nicholas Company, Inc. Nuvasive Inc Transaction History

Nicholas Company, Inc.

$5.86 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Feb 13, 2024	SELL	$36.71 - $44.15 $3,303 - $3,973	-90 Reduced 0.07%	125,815 $5.23 Million
Q2 2023 Aug 08, 2023	SELL	$36.71 - $44.15 $3,303 - $3,973	-90 Reduced 0.07%	125,815 $5.23 Million
Q4 2022 Feb 13, 2024	BUY	$35.68 - $44.71 $418,169 - $524,001	11,720 Added 10.26%	125,905 $5.19 Million
Q4 2022 Feb 09, 2023	BUY	$35.68 - $44.71 $418,169 - $524,001	11,720 Added 10.26%	125,905 $5.19 Million
Q2 2022 Feb 13, 2024	SELL	$46.84 - $59.75 $1,639 - $2,091	-35 Reduced 0.03%	114,185 $5.61 Million
Q2 2022 Jul 26, 2022	SELL	$46.84 - $59.75 $1,639 - $2,091	-35 Reduced 0.03%	114,185 $5.61 Million
Q1 2022 Feb 13, 2024	BUY	$48.09 - $57.79 $5.49 Million - $6.6 Million	114,220 New	114,220 $6.48 Million
Q1 2022 May 11, 2022	SELL	$48.09 - $57.79 $961 - $1,155	-20 Reduced 0.02%	114,220 $6.48 Million
Q4 2021 Feb 11, 2022	SELL	$47.19 - $62.68 $463,405 - $615,517	-9,820 Reduced 7.92%	114,240 $6 Million
Q3 2021 Nov 15, 2021	BUY	$56.91 - $67.81 $284 - $339	5 Added 0.0%	124,060 $7.43 Million
Q2 2021 Aug 12, 2021	SELL	$64.02 - $71.72 $95,069 - $106,504	-1,485 Reduced 1.18%	124,055 $8.41 Million
Q1 2021 May 14, 2021	BUY	$53.26 - $68.08 $1.54 Million - $1.96 Million	28,845 Added 29.83%	125,540 $8.23 Million
Q4 2020 Feb 10, 2021	SELL	$43.41 - $56.51 $7.5 Million - $9.77 Million	-172,860 Reduced 64.13%	96,695 $5.45 Million
Q3 2020 Nov 13, 2020	SELL	$47.43 - $60.75 $15,651 - $20,047	-330 Reduced 0.12%	269,555 $13.1 Million
Q2 2020 Aug 13, 2020	BUY	$43.51 - $66.59 $22,190 - $33,960	510 Added 0.19%	269,885 $15 Million
Q1 2020 May 13, 2020	SELL	$32.82 - $81.13 $358,558 - $886,345	-10,925 Reduced 3.9%	269,375 $13.6 Million
Q4 2019 Feb 13, 2020	SELL	$60.96 - $77.7 $3,048 - $3,885	-50 Reduced 0.02%	280,300 $21.7 Million
Q3 2019 Nov 14, 2019	BUY	$55.78 - $68.08 $340,258 - $415,288	6,100 Added 2.22%	280,350 $17.8 Million
Q2 2019 Aug 13, 2019	BUY	$53.69 - $65.47 $1.09 Million - $1.33 Million	20,335 Added 8.01%	274,250 $16.1 Million
Q1 2019 May 14, 2019	SELL	$44.53 - $58.9 $1.24 Million - $1.64 Million	-27,825 Reduced 9.88%	253,915 $14.4 Million
Q4 2018 Feb 14, 2019	BUY	$47.64 - $71.26 $23,820 - $35,630	500 Added 0.18%	281,740 $14 Million
Q3 2018 Nov 14, 2018	BUY	$52.03 - $71.41 $259,369 - $355,978	4,985 Added 1.8%	281,240 $20 Million
Q2 2018 Aug 14, 2018	BUY	$48.15 - $56.68 $4.16 Million - $4.9 Million	86,385 Added 45.5%	276,255 $14.4 Million
Q1 2018 May 14, 2018	BUY	$46.03 - $61.28 $3.25 Million - $4.32 Million	70,540 Added 59.11%	189,870 $9.91 Million
Q4 2017 Feb 14, 2018	SELL	$50.58 - $60.79 $5.87 Million - $7.06 Million	-116,075 Reduced 49.31%	119,330 $6.98 Million
Q3 2017 Nov 14, 2017	BUY	$53.54 - $68.0 $4.18 Million - $5.31 Million	78,075 Added 49.62%	235,405 $13.1 Million
Q2 2017 Aug 11, 2017	BUY	N/A	157,330	157,330 $12.1 Million

Others Institutions Holding NUVA

# of Institutions

Shares Held

116K

Call Options Held

Put Options Held

View Full List

About NUVASIVE INC

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

More about NUVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.

Account